Kyungdong Pharmaceutical, 15.5 Billion Won in Additional Fines... "Payment Within Deadline"
Kyungdong Pharmaceutical announced on the 27th that it received an additional tax assessment of 15.5 billion KRW from the Central Regional Tax Office. This amount corresponds to 6.03% of its equity capital. The additional tax was imposed due to a comprehensive corporate tax audit.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
Kyungdong Pharmaceutical stated, "The imposed amount is the total of the expected notification amount, including the additional tax indicated in the audit result notice, and we plan to pay it within the deadline." They added, "If there is any objection, we intend to respond through legal appeals or objections in accordance with relevant laws within the legal application period."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
